Last reviewed · How we verify
Levetiracetam Oral Product
Levetiracetam Oral Product is a Small molecule drug developed by National Cheng Kung University. It is currently in Phase 1 development. Also known as: keppra.
At a glance
| Generic name | Levetiracetam Oral Product |
|---|---|
| Also known as | keppra |
| Sponsor | National Cheng Kung University |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
- Headache
- Fatigue
- Nausea
- Constipation
- Mental Status Change
- Dizziness
- Seizure
- Somnolence
- Insomnia
- Confusion
- Facial Swelling
- Incision Pain
Key clinical trials
- A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation (PHASE2)
- A Study to Investigate JNJ-40411813 in Combination With Levetiracetam or Brivaracetam in Epilepsy (PHASE2)
- Early Initiated Ambulance-delivered Levetiracetam and Headposition in Hyper-acute Stroke Trial (PHASE3)
- Effect of Perampanel on Peritumoral Hyperexcitability in HGG (PHASE1, PHASE2)
- An Investigation of Levetiracetam in Alzheimer's Disease (PHASE2)
- 1 Week Versus 6 Weeks of Levetiracetam in Surgical Brain Tumor Patients (PHASE4)
- Post-stroke Epilepsy: Primary Prophylaxis Study (NA)
- Pharmacological Management of Seizures Post Traumatic Brain Injury (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Levetiracetam Oral Product CI brief — competitive landscape report
- Levetiracetam Oral Product updates RSS · CI watch RSS
- National Cheng Kung University portfolio CI
Frequently asked questions about Levetiracetam Oral Product
What is Levetiracetam Oral Product?
Levetiracetam Oral Product is a Small molecule drug developed by National Cheng Kung University.
Who makes Levetiracetam Oral Product?
Levetiracetam Oral Product is developed by National Cheng Kung University (see full National Cheng Kung University pipeline at /company/national-cheng-kung-university).
Is Levetiracetam Oral Product also known as anything else?
Levetiracetam Oral Product is also known as keppra.
What development phase is Levetiracetam Oral Product in?
Levetiracetam Oral Product is in Phase 1.
What are the side effects of Levetiracetam Oral Product?
Common side effects of Levetiracetam Oral Product include Headache, Fatigue, Nausea, Constipation, Mental Status Change, Dizziness.
Related
- Manufacturer: National Cheng Kung University — full pipeline
- Also known as: keppra
- Compare: Levetiracetam Oral Product vs similar drugs
- Pricing: Levetiracetam Oral Product cost, discount & access